Home / ICT / Global Pharmaceutical Asset Performance Management (APM) Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

Global Pharmaceutical Asset Performance Management (APM) Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

Published: May 2019 | No Of Pages: 92 | Published By: QYResearch

Summary 

Asset performance management (APM) is a proven approach to reduce unplanned downtime, decrease maintenance costs, and reduce EH&S risks.

Pharmaceutical Asset Performance Management (APM) are mainly classified into the following types: APM Integrity, APM Reliability etc. APM Integrity, is the most widely used type which takes up about 46.1% of the total sales in 2018.

United States is the largest region of Pharmaceutical Asset Performance Management (APM) in the world in the past few years and it will keep increasing in the next few years. United States market took up about 50% the global market in 2018, while Europe and China were about 27%, 7.4%.

APM can extend Enterprise Asset Management (EAM) systems using powerful AI data and analytics. Although sales of Pharmaceutical Asset Performance Management (APM) bring a lot of opportunities, the study group recommends the new entrants who just have money but without technical advantage and downstream support, do not enter the Pharmaceutical Asset Performance Management (APM) field hastily.

In 2018, the global Pharmaceutical Asset Performance Management (APM) market size was 93 million US$ and it is expected to reach 133.1 million US$ by the end of 2025, with a CAGR of 5.3% between 2019 and 2025.

This report studies the Pharmaceutical Asset Performance Management (APM) market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

This report focuses on the global top players, covered

  • GE (US)
  • Rockwell Software (US)
  • AVEVA Group plc (UK)
  • Bentley Systems (US)
  • AspenTech (US)
  • Nexus Global (US)
  • SAP (Germany)...

Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Rest of Asia Pacific
  • Central & South America
  • Middle East & Africa

Market segment by Type, the product can be split into

  • Asset Integrity Management
  • Asset Reliability Management
  • Other

Market segment by Application, the market can be split into

  • Large Enterprises
  • SMEs

The study objectives of this report are:

  • To study and forecast the market size of Pharmaceutical Asset Performance Management (APM) in global market.
  • To analyze the global key players, SWOT analysis, value and global market share for top players.
  • To define, describe and forecast the market by type, end use and region.
  • To analyze and compare the market status and forecast among global major regions.
  • To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pharmaceutical Asset Performance Management (APM) are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

  • Raw material suppliers
  • Distributors/traders/wholesalers/suppliers
  • Regulatory bodies, including government agencies and NGO
  • Commercial research & development (R&D) institutions
  • Importers and exporters
  • Government organizations, research organizations, and consulting firms
  • Trade associations and industry bodies
  • End-use industries

1 Industry Overview of Pharmaceutical Asset Performance Management (APM)

1.1 Pharmaceutical Asset Performance Management (APM) Market Overview

1.1.1 Pharmaceutical Asset Performance Management (APM) Product Scope

1.1.2 Market Status and Outlook

1.2 Global Pharmaceutical Asset Performance Management (APM) Market Size and Analysis by Regions

1.2.1 North America

1.2.2 Europe

1.2.3 China

1.2.4 Rest of Asia Pacific

1.2.5 Central & South America

1.2.6 Middle East & Africa

1.3 Pharmaceutical Asset Performance Management (APM) Market by Type

1.3.1 Global Pharmaceutical Asset Performance Management (APM) Revenue (Million US$) and Growth Comparison by Type (2014-2025)

1.3.2 Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Type in 2018

1.3.3 Asset Integrity Management

1.3.4 Asset Reliability Management

1.3.5 Other

1.4 Pharmaceutical Asset Performance Management (APM) Market by End Users/Application

1.4.1 Large Enterprises

1.4.2 SMEs

 

2 Global Pharmaceutical Asset Performance Management (APM) Competition Analysis by Players

2.1 Global Pharmaceutical Asset Performance Management (APM) Market Size (Million US$) by Players (2014-2019)

2.2 Competitive Status

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 Mergers & Acquisitions, Expansion Plans

 

3 Company (Top Players) Profiles and Key Data

3.1 GE (US)

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Pharmaceutical Asset Performance Management (APM) Revenue (Value) (2014-2019)

3.1.5 Recent Developments

3.2 Rockwell Software (US)

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Pharmaceutical Asset Performance Management (APM) Revenue (Value) (2014-2019)

3.2.5 Recent Developments

3.3 AVEVA Group plc (UK)

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Pharmaceutical Asset Performance Management (APM) Revenue (Value) (2014-2019)

3.3.5 Recent Developments

3.4 Bentley Systems (US)

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Pharmaceutical Asset Performance Management (APM) Revenue (Value) (2014-2019)

3.4.5 Recent Developments

3.5 AspenTech (US)

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Pharmaceutical Asset Performance Management (APM) Revenue (Value) (2014-2019)

3.5.5 Recent Developments

3.6 Nexus Global (US)

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Pharmaceutical Asset Performance Management (APM) Revenue (Value) (2014-2019)

3.6.5 Recent Developments

3.7 SAP (Germany)

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Pharmaceutical Asset Performance Management (APM) Revenue (Value) (2014-2019)

3.7.5 Recent Developments

 

4 Global Pharmaceutical Asset Performance Management (APM) Market Size by Type and Application (2014-2019)

4.1 Global Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019)

4.2 Global Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019)

4.3 Potential Application of Pharmaceutical Asset Performance Management (APM) in Future

4.4 Top Consumer/End Users of Pharmaceutical Asset Performance Management (APM)

 

5 North America Pharmaceutical Asset Performance Management (APM) Development Status and Outlook

5.1 North America Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)

5.2 North America Pharmaceutical Asset Performance Management (APM) Market Size and Market Share by Players (2014-2019)

5.3 North America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019)

 

6 Europe Pharmaceutical Asset Performance Management (APM) Development Status and Outlook

6.1 Europe Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)

6.2 Europe Pharmaceutical Asset Performance Management (APM) Market Size and Market Share by Players (2014-2019)

6.3 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019)

 

7 China Pharmaceutical Asset Performance Management (APM) Development Status and Outlook

7.1 China Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)

7.2 China Pharmaceutical Asset Performance Management (APM) Market Size and Market Share by Players (2014-2019)

7.3 China Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019)

 

8 Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Development Status and Outlook

8.1 Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)

8.2 Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size and Market Share by Players (2014-2019)

8.3 Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019)

 

9 Central & South America Pharmaceutical Asset Performance Management (APM) Development Status and Outlook

9.1 Central & South America Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)

9.2 Central & South America Pharmaceutical Asset Performance Management (APM) Market Size and Market Share by Players (2014-2019)

9.3 Central & South America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019)

 

10 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Development Status and Outlook

10.1 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)

10.2 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size and Market Share by Players (2014-2019)

10.3 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019)

 

11 Market Forecast by Regions, Type and Application (2019-2025)

11.1 Global Pharmaceutical Asset Performance Management (APM) Market Size by Regions (2019-2025)

11.1.1 North America Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2019-2025)

11.1.2 Europe Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2019-2025)

11.1.3 China Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2019-2025)

11.1.4 Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2019-2025)

11.1.5 Central & South America Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2019-2025)

11.1.6 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Revenue and Growth Rate (2019-2025)

11.2 Global Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2025)

11.3 Global Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2025)

 

12 Pharmaceutical Asset Performance Management (APM) Market Dynamics

12.1 Industry Trends

12.2 Market Drivers

12.3 Market Challenges

12.4 Porter’s Five Forces Analysis

 

13 Research Finding /Conclusion

 

14 Methodology and Data Source

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

14.4 Author List

Figure Global Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) Status and Outlook (2014-2025)

Table Global Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) and Growth Rate by Regions (2014-2025)

Figure Global Pharmaceutical Asset Performance Management (APM) Market Share by Regions (2014-2019)

Figure North America Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) and Growth Rate (2014-2019)

Figure Europe Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) and Growth Rate (2014-2019)

Figure China Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) and Growth Rate (2014-2019)

Figure Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) and Growth Rate (2014-2019)

Figure Central & South America Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) and Growth Rate (2014-2019)

Figure Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) and Growth Rate (2014-2019)

Figure Global Pharmaceutical Asset Performance Management (APM) Market Share by Type in 2018 & 2025

Figure Asset Integrity Management Market Size (Million USD) and Growth Rate (2014-2019)

Figure Asset Reliability Management Market Size (Million USD) and Growth Rate (2014-2019)

Figure Other Market Size (Million USD) and Growth Rate (2014-2019)

Table Global Pharmaceutical Asset Performance Management (APM) Market Size (Million US$) Comparison by Application (2014-2025)

Figure Global Pharmaceutical Asset Performance Management (APM) Market Share by Application in 2018 & 2025

Figure Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) and Growth Rate in Large Enterprises (2014-2019)

Figure Pharmaceutical Asset Performance Management (APM) Market Size (Million USD) and Growth Rate in SMEs (2014-2019)

Table Global Pharmaceutical Asset Performance Management (APM) Revenue (Million US$) by Players (2014-2019)

Table Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Players (2014-2019)

Eigure Pharmaceutical Asset Performance Management (APM) Market Size Share by Players in 2018

Table Global Pharmaceutical Asset Performance Management (APM) Manufacturers Market Concentration Ratio (CR5 and HHI)

Figure Global Top 5 Players Pharmaceutical Asset Performance Management (APM) Market Share in 2018

Figure Global Top 10 Players Pharmaceutical Asset Performance Management (APM) Market Share in 2018

Table Pharmaceutical Asset Performance Management (APM) Key Players Product/Service

Table Mergers & Acquisitions, Expansion Plans

Table GE (US) Basic Information List

Table GE (US) Description and Business Overview

Table GE (US) Pharmaceutical Asset Performance Management (APM) Products, Services and Solutions

Table Revenue (Million US$) in Pharmaceutical Asset Performance Management (APM) Business of GE (US) (2014-2019)

Table GE (US) Pharmaceutical Asset Performance Management (APM) Recent Developments

Table Rockwell Software (US) Basic Information List

Table Rockwell Software (US) Description and Business Overview

Table Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Products, Services and Solutions

Table Revenue (Million US$) in Pharmaceutical Asset Performance Management (APM) Business of Rockwell Software (US) (2014-2019)

Table Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Recent Developments

Table AVEVA Group plc (UK) Basic Information List

Table AVEVA Group plc (UK) Description and Business Overview

Table AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Products, Services and Solutions

Table Revenue (Million US$) in Pharmaceutical Asset Performance Management (APM) Business of AVEVA Group plc (UK) (2014-2019)

Table AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Recent Developments

Table Bentley Systems (US) Basic Information List

Table Bentley Systems (US) Description and Business Overview

Table Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Products, Services and Solutions

Table Revenue (Million US$) in Pharmaceutical Asset Performance Management (APM) Business of Bentley Systems (US) (2014-2019)

Table Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Recent Developments

Table AspenTech (US) Basic Information List

Table AspenTech (US) Description and Business Overview

Table AspenTech (US) Pharmaceutical Asset Performance Management (APM) Products, Services and Solutions

Table Revenue (Million US$) in Pharmaceutical Asset Performance Management (APM) Business of AspenTech (US) (2014-2019)

Table AspenTech (US) Pharmaceutical Asset Performance Management (APM) Recent Developments

Table Nexus Global (US) Basic Information List

Table Nexus Global (US) Description and Business Overview

Table Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Products, Services and Solutions

Table Revenue (Million US$) in Pharmaceutical Asset Performance Management (APM) Business of Nexus Global (US) (2014-2019)

Table Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Recent Developments

Table SAP (Germany) Basic Information List

Table SAP (Germany) Description and Business Overview

Table SAP (Germany) Pharmaceutical Asset Performance Management (APM) Products, Services and Solutions

Table Revenue (Million US$) in Pharmaceutical Asset Performance Management (APM) Business of SAP (Germany) (2014-2019)

Table SAP (Germany) Pharmaceutical Asset Performance Management (APM) Recent Developments

Table Global Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019) (Million US$)

Figure Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Type in 2018

Table Global Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019) (Million US$)

Figure Global Pharmaceutical Asset Performance Management (APM) Revenue Market by Application in 2018

Table Top Consumer/End Users of Pharmaceutical Asset Performance Management (APM)

Figure North America Pharmaceutical Asset Performance Management (APM) Market Size and Growth Rate(2014-2019) (Million USD)

Table North America Pharmaceutical Asset Performance Management (APM) Market Size by Players (2014-2019)(Million US$)

Figure North America Pharmaceutical Asset Performance Management (APM) Market Size Share by Players in 2018

Table North America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019) (Million US$)

Figure North America Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Application (2014-2019)

Figure North America Pharmaceutical Asset Performance Management (APM) Market Size Share by Application in 2018

Figure Europe Pharmaceutical Asset Performance Management (APM) Market Size and Growth Rate(2014-2019) (Million USD)

Table Europe Pharmaceutical Asset Performance Management (APM) Market Size by Players (2014-2019)(Million US$)

Figure Europe Pharmaceutical Asset Performance Management (APM) Market Size Share by Players in 2018

Table Europe Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019) (Million US$)

Figure Europe Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Application (2014-2019)

Figure Europe Pharmaceutical Asset Performance Management (APM) Market Size Share by Application in 2018

Figure China Pharmaceutical Asset Performance Management (APM) Market Size and Growth Rate(2014-2019) (Million USD)

Table China Pharmaceutical Asset Performance Management (APM) Market Size by Players (2014-2019)(Million US$)

Figure China Pharmaceutical Asset Performance Management (APM) Market Size Share by Players in 2018

Table China Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019) (Million US$)

Figure China Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Application (2014-2019)

Figure China Pharmaceutical Asset Performance Management (APM) Market Size Share by Application in 2018

Figure Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size and Growth Rate(2014-2019) (Million USD)

Table Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size by Players (2014-2019)(Million US$)

Figure Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size Share by Players in 2018

Table Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019) (Million US$)

Figure Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Application (2014-2019)

Figure Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size Share by Application in 2018

Figure Central & South America Pharmaceutical Asset Performance Management (APM) Market Size and Growth Rate(2014-2019) (Million USD)

Table Central & South America Pharmaceutical Asset Performance Management (APM) Market Size by Players (2014-2019)(Million US$)

Figure Central & South America Pharmaceutical Asset Performance Management (APM) Market Size Share by Players in 2018

Table Central & South America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019) (Million US$)

Figure Central & South America Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Application (2014-2019)

Figure Central & South America Pharmaceutical Asset Performance Management (APM) Market Size Share by Application in 2018

Figure Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size and Growth Rate(2014-2019) (Million USD)

Table Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size by Players (2014-2019)(Million US$)

Figure Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size Share by Players in 2018

Table Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019) (Million US$)

Figure Middle East & Africa Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Application (2014-2019)

Figure Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size Share by Application in 2018

Figure Global Pharmaceutical Asset Performance Management (APM) Market Size and Growth Rate (Value) (2019-2025) (Million US$)

Table Global Pharmaceutical Asset Performance Management (APM) Market Size by Regions (2019-2025) (Million US$)

Figure Global Pharmaceutical Asset Performance Management (APM) Market Size Share by Regions (2019-2025)

Figure Global Pharmaceutical Asset Performance Management (APM) Market Size Share by Regions in 2025

Figure North America Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2019-2025)

Figure Europe Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2019-2025)

Figure China Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2019-2025)

Figure Rest of Asia Pacific Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2019-2025)

Figure Central & South America Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2019-2025)

Figure Middle East & Africa Pharmaceutical Asset Performance Management (APM) Revenue (Million USD) and Growth Rate (2019-2025)

Table Global Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2025) (Million USD)

Figure Global Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2025)

Figure Global Pharmaceutical Asset Performance Management (APM) Market Size by Application in 2025

Table Global Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2025) (Million US$)

Figure Global Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2025)

Figure Global Pharmaceutical Asset Performance Management (APM) Market Size by Type in 2025

Table Market Top Trends

Table Key Drivers: Impact Analysis (2019-2025)

Table Key Challenges

Figure Porter's Five Forces Analysis

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +